Rainbow Childrens Medicare Results Earnings Call for Q3FY23
Conference Call with Rainbow Childrens Medicare Management and Analysts on Q3FY23 Performance and Outlook. Listen to the full earnings transcript.10-02-2023
10-02-2023
Q3FY23 Quarterly Result Announced for Rainbow Childrens Medicare Ltd.
Rainbow Children Medicare announced Q3FY23 results: Q3FY23: Revenues for Q3FY23 stood at Rs 3,064.04 million, growth of 23.17% compared to Rs 2,487.56 million in Q3FY22. EBIDTA for Q3FY23 was Rs 1,067.56 million, growth of 19.59% compared to Rs 892.68 million in Q3FY22 PAT for Q3 FY23 was Rs 582.44 million, growth of 28.87% compared to Rs 451.95 million in Q3FY22. Commenting on the performance for Q3FY23, Ramesh Kancharla, Chairman & Managing Director, Rainbow Children’s Medicare Limited (RCML), said, “I am pleased to inform you that the company has delivered robust quarterly performance, led by high patient footfalls across hospitals in every geography. We are pleased to share that the projects which are under execution are progressing well and will commence operations within the targeted timelines.” Result PDF09-02-2023
Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Earnings Presentation of the Company on Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months ended December 31, 2022, which the Company proposes to share with analysts/ investors.09-02-2023
Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith the Press Release for the Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months ended December 31, 2022.09-02-2023
Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 41 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, we are enclosing herewith the Monitoring Agency Report dated February 7, 2023, issued by HDFC Bank Limited, Monitoring Agency, for the quarter ended December 31, 2022 in respect of utilization of proceeds of the Initial Public Offer of the Company.09-02-2023
Rainbow Children's Medicare Ltd - 543524 - Statement On Deviation Or Variation In Utilisation Of Funds Raised Though Initial Public Offer (''''IPO'''') For The Quarter Ended December 31, 2022
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended read with SEBI Circular No.CIR/CFD/CMDl/162/2019 dated December 24, 2019, we hereby confirm that during the quarter ended December 31, 2022, there was no deviation or variation in the utilisation of proceeds of the IPO from the objects stated in the Prospectus dated May 2, 2022. A statement of deviation or variation for the quarter ended December 31, 2022, duly reviewed by the Audit Committee of the Company, is enclosed herewith.09-02-2023
Rainbow Children's Medicare Ltd - 543524 - Board Meeting Outcome for Outcome Of The Board Meeting Held On February 9, 2023.
Please take note that the Board of Directors of the Company in their meeting held today i.e. February 9, 2023, approved Unaudited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Nine Months ended December 31, 2022. Copy of the signed Results along with Limited Review Reports issued by the Statutory Auditors M/s. BSR & Associates LLP are attached herewith.09-02-2023
Rainbow Children's Medicare Ltd - 543524 - Financial Results For The Quarter And Nine Months Ended December 31, 2022.
Please take note that the Board of Directors of the Company in their meeting held today i.e. February 9, 2023, approved Unaudited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Nine Months ended December 31, 2022. Copy of the signed Results along with Limited Review Reports issued by the Statutory Auditors M/s. BSR & Associates LLP, are attached herewith.09-02-2023
Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015, please find attached the invite of the Conference Call for Investors/ Analysts to be held on Friday, February 10, 2023 at 10:30 A.M IST to discuss the financial and operating performance for Q3 & 9M FY 23.02-02-2023
Rainbow Children's Medicare Ltd - 543524 - Board Meeting Intimation for Board Meeting Intimation To Inter-Alia Consider And Approve The Un-Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2022.
Rainbow Children''s Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 ,inter alia, to consider and approve the Un-Audited (Standalone & Consolidated) Financial results of the Company for the Quarter and Nine Months ended December 31, 2022.01-02-2023